|
|
|
|
|
by epistasis
4607 days ago
|
|
In the important areas, it does check itself. If a scientist has been doing some interesting work, she will soon find herself with colleagues working on the same area. If she has not been doing something interesting, that line of research does not get cited, dies out, and does not get funding. In active learning, there's a tradeoff between exploration and exploitation. Science does this too, but heuristically. |
|
- 16% were found by later studies to be wrong
- 16% were found to have exaggerated the size of effects they claimed to detect
- 44% were replicated, and
- 24% were unchallenged and unreplicated by later literature.
So a full quarter of incredibly prominent research was never tested.
Ioannidis, J. P. A. (2005). Contradicted and initially stronger effects in highly cited clinical research. JAMA, 294(2), 218–228. doi:10.1001/jama.294.2.218